OPKO Health ROA 2010-2024 | OPK

Current and historical return on assets (ROA) values for OPKO Health (OPK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
OPKO Health ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-03-31 $-0.25B $1.97B -12.29%
2023-12-31 $-0.19B $2.01B -8.95%
2023-09-30 $-0.21B $2.06B -9.68%
2023-06-30 $-0.21B $2.16B -9.59%
2023-03-31 $-0.29B $2.17B -13.03%
2022-12-31 $-0.33B $2.17B -14.47%
2022-09-30 $-0.32B $2.23B -13.63%
2022-06-30 $-0.20B $2.37B -8.51%
2022-03-31 $-0.12B $2.31B -4.86%
2021-12-31 $-0.03B $2.40B -1.23%
2021-09-30 $0.08B $2.42B 3.09%
2021-06-30 $0.07B $2.42B 2.90%
2021-03-31 $0.12B $2.52B 5.00%
2020-12-31 $0.03B $2.47B 1.32%
2020-09-30 $-0.11B $2.37B -4.89%
2020-06-30 $-0.20B $2.32B -8.62%
2020-03-31 $-0.29B $2.23B -12.51%
2019-12-31 $-0.32B $2.31B -12.98%
2019-09-30 $-0.28B $2.37B -11.33%
2019-06-30 $-0.25B $2.46B -9.84%
2019-03-31 $-0.19B $2.58B -7.61%
2018-12-31 $-0.15B $2.45B -6.09%
2018-09-30 $-0.30B $2.48B -11.59%
2018-06-30 $-0.30B $2.53B -11.63%
2018-03-31 $-0.31B $2.58B -11.78%
2017-12-31 $-0.31B $2.59B -11.29%
2017-09-30 $-0.13B $2.72B -4.54%
2017-06-30 $-0.10B $2.77B -3.75%
2017-03-31 $-0.07B $2.76B -2.56%
2016-12-31 $-0.05B $2.77B -1.72%
2016-09-30 $-0.01B $2.80B -0.32%
2016-06-30 $0.13B $2.77B 4.71%
2016-03-31 $0.08B $2.79B 2.96%
2015-12-31 $-0.03B $2.80B -1.36%
2015-09-30 $-0.09B $3.02B -4.64%
2015-06-30 $-0.26B $1.53B -18.71%
2015-03-31 $-0.24B $1.51B -18.07%
2014-12-31 $-0.17B $1.27B -13.11%
2014-09-30 $-0.14B $1.30B -10.13%
2014-06-30 $-0.15B $1.33B -10.77%
2014-03-31 $-0.13B $1.36B -10.48%
2013-12-31 $-0.12B $1.39B -11.30%
2013-09-30 $-0.10B $1.38B -13.34%
2013-06-30 $-0.05B $0.64B -10.68%
2013-03-31 $-0.06B $0.65B -16.01%
2012-12-31 $-0.03B $0.29B -12.38%
2012-09-30 $-0.01B $0.25B -5.10%
2012-06-30 $-0.01B $0.23B -5.23%
2012-03-31 $-0.01B $0.23B -3.11%
2011-12-31 $-0.00B $0.23B -1.68%
2011-09-30 $-0.02B $0.15B -15.58%
2011-06-30 $-0.02B $0.16B -17.43%
2011-03-31 $-0.02B $0.18B -22.56%
2010-12-31 $-0.02B $0.08B -27.91%
2010-09-30 $-0.03B $0.07B -38.71%
2010-06-30 $-0.03B $0.07B -39.26%
2010-03-31 $-0.03B $0.09B -38.99%
2009-12-31 $-0.04B $0.09B -56.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.920B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.518B 27.33
Intuitive Surgical (ISRG) United States $142.199B 85.66
Edwards Lifesciences (EW) United States $54.361B 35.38
DexCom (DXCM) United States $51.910B 78.63
Alcon (ALC) Switzerland $44.749B 32.07
IDEXX Laboratories (IDXX) United States $42.775B 50.14
IQVIA Holdings (IQV) United States $41.183B 23.89
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.691B 30.41
SONOVA HOLDING (SONVY) Switzerland $18.917B 0.00
Hologic (HOLX) United States $17.459B 19.53
ShockWave Medical (SWAV) United States $12.540B 78.04
Fresenius Medical Care AG KGaA (FMS) Germany $12.235B 14.28
Sysmex ADR (SSMXY) Japan $10.844B 34.01
Teleflex (TFX) United States $10.037B 15.62
Globus Medical (GMED) United States $9.090B 26.65
Penumbra (PEN) United States $7.713B 87.65
Masimo (MASI) United States $6.721B 38.72
Glaukos (GKOS) United States $5.426B 0.00
TransMedics (TMDX) United States $4.511B 428.03
Integer Holdings (ITGR) United States $4.073B 24.61
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $3.280B 19.48
Elekta AB (EKTAY) Sweden $3.078B 21.12
Inari Medical (NARI) United States $2.771B 0.00
Nihon Kohden (NHNKY) Japan $2.493B 21.08
RxSight (RXST) United States $2.285B 0.00
Integra LifeSciences Holdings (IART) United States $2.216B 9.66
Veracyte (VCYT) United States $1.653B 0.00
Alphatec Holdings (ATEC) United States $1.505B 0.00
Artivion (AORT) United States $0.991B 95.04
AVANOS MEDICAL, INC (AVNS) United States $0.935B 18.18
Silk Road Medical (SILK) United States $0.878B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Pulse Biosciences (PLSE) United States $0.659B 0.00
Paragon 28 (FNA) United States $0.653B 0.00
Mesa Laboratories (MLAB) United States $0.617B 20.94
SiBone (SIBN) United States $0.578B 0.00
IRadimed (IRMD) United States $0.551B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.504B 0.00
Nevro (NVRO) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.331B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AxoGen (AXGN) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
908 Devices (MASS) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Delcath Systems (DCTH) United States $0.218B 0.00
Inogen (INGN) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.184B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.165B 8.37
Accuray (ARAY) United States $0.152B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.096B 20.10
Neuronetics (STIM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
DarioHealth (DRIO) United States $0.052B 0.00
Autonomix Medical (AMIX) United States $0.048B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00